Single Photon Emission Computed Tomography of the Normal Human Brain
Launched by AMEN CLINICS, INC. · Sep 15, 2010
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
See brief summary.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The study seeks to recruit 100 normal human subjects between ages 10 and 90 for SPECT brain imaging. Subjects will initially be screened for psychiatric and other major illnesses with a screening questionnaire; they will also be given a standard DSM-4 computer-administered questionnaire (The DISC for children and teens and the SCID for adults). They will also meet individually with a psychiatrist or psychological assistant for a screening interview.
- Exclusion Criteria:
- • 1. Suicidal thinking or behavior
- • 2. Any psychiatric diagnosis assignable under contemporary DSM nosology
- • 3. Unstable medical condition
- • 4. epilepsy, serious head injury, or other significant neurological disorder or use of central nervous system medication.
- • 5. Dementia, mental retardation, or coma
- • 6. Substance abuse or alcoholism
- • 7. Unreliability or inability to adhere to the requirements of the study
- • 8. Inability to personally tolerate the requirements of the study
- • 9. Significant exposure to occupational, diagnostic, or therapeutic radiation within the prior year
- • 10. Pregnancy or breast-feeding
- • 11. A first-degree relative meeting any of criteria 1 through 6.
About Amen Clinics, Inc.
Amen Clinics, Inc. is a leading provider of innovative mental health solutions, specializing in the comprehensive assessment and treatment of various psychiatric conditions. With a focus on brain health, the organization employs advanced neuroimaging techniques, including SPECT scans, to identify underlying issues contributing to mental health disorders. Amen Clinics is dedicated to integrating scientific research with personalized care, offering evidence-based treatment protocols that address the unique needs of each patient. Through clinical trials and ongoing research initiatives, the clinic strives to advance the understanding of mental health and improve therapeutic outcomes for individuals across diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newport Beach, California, United States
Patients applied
Trial Officials
Daniel G Amen, MD
Principal Investigator
Amen Clinics, Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials